Home 2016
Archives
SABCS: Rx Combo Promising in Advanced HR+, HER2− Breast CA
Everolimus added to fulvestrant appears to improve progression-free survival
SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects
Perceived side effects might lead some to stop taking the medication, researchers say
Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC
Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed
ASH: Single Dose of Gene Therapy Effective in Hemophilia B
Small, preliminary trial suggests it may free hemophilia B patients from transfusions
SABCS: Molecular Changes Occur When Breast CA Spreads to Brain
Finding might lead to better treatment, researchers say
Epilepsy Onset Not Uncommon After Stroke
Patients with greater brain damage more likely to have seizures afterwards, researchers find
Measures Sought to ID Epilepsy Patients Who Are Safe to Drive
Those with longer seizures during driving tests more likely to have accidents
Cannabidiol May Help Treat Intractable Epilepsy
CBD lowers seizure frequency, severity in some patients with Dravet, Lennox-Gastaut syndromes
SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years
Study found women who continued with letrozole did experience other benefits, however
ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing
Synthetic product made from purified human hemoglobin proteins coated with a synthetic polymer
